Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): Influence of N-linked glycosylation

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9741-9752

  Wentworth, D E ^a   Holmes, K V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSOMAL AMINOPEPTIDASE; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CAT; CORONAVIRUS; GENE INSERTION; GLYCOSYLATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR BINDING; SWINE; VIRUS MUTANT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, CD13; BINDING SITES; CELL LINE; CORONAVIRUS; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; CORONAVIRUS, FELINE; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRULENCE;

EID: 0034811621     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9741-9752.2001     Document Type: Article

References (78)

1. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
2. M3 CD13 (aminopeptidase N) cluster workshop report. 1. Leucocyte typing V
3. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation
4. Localization of aminopeptidase N and dipeptidyl peptidase IV in pig striatum and in neuronal and glial cell cultures
5. The time course of the immune response to experimental coronavirus infection of man
6. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
7. SF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
8. Co- and post-translational events in the biogenesis of pig small intestinal aminopeptidase N
9. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site
10. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV
11. Further characterization of aminopeptidase-N as a receptor for coronaviruses
12. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence
13. Strategies used by human immunodeficiency virus that allow persistent viral replication
14. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
15. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV
16. Evolution of a simian immunodeficiency virus pathogen
17. Glycosylation-dependent inactivation of the ecotropic murine leukemia virus receptor
18. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
19. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13
20. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein
21. Neutralization of human cytomegalovirus by human CD13-specific antibodies
22. Characterization of determinants involved in the feline infectious peritonitis virus receptor function of feline aminopeptidase N
23. Intracellular functions of N-linked glycans
24. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4
25. Coronaviridae: The viruses and their replication
26. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding
27. Glycosylation of a synthetic peptide representing a T-cell determinant of influenza virus hemagglutinin results in loss of recognition by CD4+ T-cell clones
28. Regulation of N-linked core glycosylation: Use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors
29. Topology of microvillar membrance hydrolases of kidney and intestine
30. Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation
31. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities
32. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor
33. Molecular analysis of the coronavirus-receptor function of aminopeptidase N
34. Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N
35. Characterization of functional domains in the human coronavirus HCV 229E receptor
36. Intracellular markers in acute myeloid leukemia diagnosis
37. Pseudotyped REV/SRV retroviruses reveal restrictions to infection and host range within members of the same receptor interference group
38. The 140-kDa protein of blood-brain barrier-associated pericytes is identical to aminopeptidase N
39. Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E
40. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histo-compatibility complex class II-bound peptides
41. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: Implications for prevention of CMV transmission
42. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N
43. The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor
44. Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor
45. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2
46. Analysis of the unique hamster cell tropism of ecotropic murine leukemia virus PVC-211
47. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties
48. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N
49. The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency
50. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells
51. Detection of coronavirus RNA and antigen in multiple sclerosis brain
52. Temporal association of the N- and O-linked glycosylation events and their implication in the polarized sorting of intestinal brush border sucrase-isomaltase, aminopeptidase N, and dipeptidyl peptidase IV
53. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion
54. Aminopeptidase N
55. Antigenic and genetic analysis of a recently isolated H1N1 swine influenza virus
56. A novel carbohydrate addition site on the hemagglutinin protein of a highly pathogenic H7 subtype avian influenza virus
57. Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13
58. Antigenic and phenotypic variants of a virulent avian influenza virus selected during replication in ducks
59. CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: The role of the N-terminal domain of CXCR-4 in fusion and entry
60. CD13 - Not just a marker in leukemia typing
61. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation
62. Anchoring and biosynthesis of stalked brush border membrane proteins: Glycosidases and peptidases of enterocytes and renal tubuli
63. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection
64. Cytomegalovirus-induced CD13-specific autoimmunity - A possible cause of chronic graft-vs-host disease
65. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients
66. Immunoelectron microscopic single and double labelling of aminopeptidase N (CD 13) and dipeptidyl peptidase IV (CD 26)
67. Lineage identification of acute leukemias: Relevance of immunologic and ultrastructural techniques
68. Human coronavirus gene expression in the brains of multiple sclerosis patients
69. Neurotropism of human coronavirus 229E
70. Variable transduction efficiency of murine leukemia retroviral vector on mammalian cells: Role of cellular glycosylation
71. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I
72. Pathogenesis of viral infections
73. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter
74. Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter
75. Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses
76. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: Role of glycosylation in the correct folding of the V1/V2 domain
77. Human aminopeptidase N is a receptor for human coronavirus 229E
78. Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities